(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.12% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.91%.
Aptargroup's revenue in 2026 is $3,933,243,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $255,723,300,838, with the lowest ATR revenue forecast at $245,359,576,811, and the highest ATR revenue forecast at $268,312,364,380. On average, 10 Wall Street analysts forecast ATR's revenue for 2027 to be $266,087,024,865, with the lowest ATR revenue forecast at $250,191,742,615, and the highest ATR revenue forecast at $281,282,914,696.
In 2028, ATR is forecast to generate $285,224,944,694 in revenue, with the lowest revenue forecast at $275,306,288,570 and the highest revenue forecast at $298,068,332,752.